Cibc World Markets Corp Protagonist Therapeutics, Inc Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 13,178 shares of PTGX stock, worth $661,799. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,178
Previous 5,468
141.0%
Holding current value
$661,799
Previous $211,000
201.9%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$307 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$289 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$287 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$215 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$151 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.47B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...